Therapeutic Interfering Particles Against HIV: Molecular Parasites Reducing Viremia
Overview
Overview
Journal
Signal Transduct Target Ther
Specialties
Cell Biology
Pharmacology
Pharmacology
Date
2024 Oct 14
PMID
39402038
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Bekker L, Das M, Abdool Karim Q, Ahmed K, Batting J, Brumskine W
. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. N Engl J Med. 2024; 391(13):1179-1192.
DOI: 10.1056/NEJMoa2407001.
View
2.
Pitchai F, Tanner E, Khetan N, Vasen G, Levrel C, Kumar A
. Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primates. Science. 2024; 385(6709):eadn5866.
PMC: 11545966.
DOI: 10.1126/science.adn5866.
View
3.
Dimmock N, Rainsford E, Scott P, Marriott A
. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virol. 2008; 82(17):8570-8.
PMC: 2519629.
DOI: 10.1128/JVI.00743-08.
View
4.
Notton T, Sardanyes J, Weinberger A, Weinberger L
. The case for transmissible antivirals to control population-wide infectious disease. Trends Biotechnol. 2014; 32(8):400-5.
DOI: 10.1016/j.tibtech.2014.06.006.
View
5.
Huang A, Baltimore D
. Defective viral particles and viral disease processes. Nature. 1970; 226(5243):325-7.
DOI: 10.1038/226325a0.
View